Investing Profile

Carol Gallagher

OperatorAdvisor
Venture Advisor at New Enterprise Associates (NEA)
Photo of Carol Gallagher, Advisor at New Enterprise Associates (NEA)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
10
$6.2B
CompanyStageDateRound SizeTotal Raised
Recludix Pharma
Series ANov 2021$60M
$60M
Millendo Therapeutics
Series UnknownAug 2018$30M
Series BJan 2016$62M
$92M
Metacrine
Series CJun 2018$65M
Series BDec 2017$22M
$140M
Co-investors: Anup Arora (Hercules Capital)
Pionyr Immunotherapeutics
Series BDec 2017$62M
$71M
Co-investors: Jack Kenney (SV Health Investors)
Good2Go, Inc.
Seed RoundSep 2017$7M
$7M
Co-investors: Ruby Lee
Good2Go, Inc
SeedSep 2017$7M
$7M
Co-investors: Nancy Schoendorf (Mohr Davidow Ventures)
Cleave Therapeutics
Series BAug 2016$37M
Series AApr 2013$10M
$47M
Co-investors: Robert Garland (New Enterprise Associates (NEA))